Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients

Written by ClinicalTrials.gov

Category: Muscle Diseases

Published: 08 July 2011

Condition: Duchenne Muscular Dystrophy
Intervention: Drug: AVI-4658 (Eteplirsen)
Sponsor: AVI BioPharma, Inc.
Enrolling by invitation - verified July 2011

Details: Last Updated: 08 July 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies